Manisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals.

• 1. Role of IL-1 gene polymorphisms in common solid cancers Ragini D. Singh, Sagar Dholariya, Anusmita Shekher, Avadhesh, Deepak Parchwani and Subash C. Gupta 2. The role of IL-1 in tumor growth and angiogenesis Kinjal Bhadresha, Pradeep K. Shukla and Pratibha Singh 3. Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer 4. Strategies to overcome interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer Abhishek Puthenveetil, Shweta Dubey and Ankita Garg 5. Modulation of IL-1-mediated inflammation in cancer using a food-based approach: a preventive strategy Shubhi Singh, Smriti Gaur and Manisha Singh 6. IL-1-mediated inflammation in COVID-19 Preeti Jain, Baldeep Singh, Sadhna Aggarwal and Manisha Singh 7. Role of IL-1 in bacterial infections Aishwarya Rani and Devinder Toor

Manisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals.

• 1. Role of IL-1 gene polymorphisms in common solid cancers Ragini D. Singh, Sagar Dholariya, Anusmita Shekher, Avadhesh, Deepak Parchwani and Subash C. Gupta 2. The role of IL-1 in tumor growth and angiogenesis Kinjal Bhadresha, Pradeep K. Shukla and Pratibha Singh 3. Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer 4. Strategies to overcome interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer Abhishek Puthenveetil, Shweta Dubey and Ankita Garg 5. Modulation of IL-1-mediated inflammation in cancer using a food-based approach: a preventive strategy Shubhi Singh, Smriti Gaur and Manisha Singh 6. IL-1-mediated inflammation in COVID-19 Preeti Jain, Baldeep Singh, Sadhna Aggarwal and Manisha Singh 7. Role of IL-1 in bacterial infections Aishwarya Rani and Devinder Toor

Manisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals.

• 1. Role of IL-1 gene polymorphisms in common solid cancers Ragini D. Singh, Sagar Dholariya, Anusmita Shekher, Avadhesh, Deepak Parchwani and Subash C. Gupta 2. The role of IL-1 in tumor growth and angiogenesis Kinjal Bhadresha, Pradeep K. Shukla and Pratibha Singh 3. Interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer 4. Strategies to overcome interleukin-1-mediated immune suppression and resistance to immunotherapy in cancer Abhishek Puthenveetil, Shweta Dubey and Ankita Garg 5. Modulation of IL-1-mediated inflammation in cancer using a food-based approach: a preventive strategy Shubhi Singh, Smriti Gaur and Manisha Singh 6. IL-1-mediated inflammation in COVID-19 Preeti Jain, Baldeep Singh, Sadhna Aggarwal and Manisha Singh 7. Role of IL-1 in bacterial infections Aishwarya Rani and Devinder Toor